As more people seek treatment for these infections, the demand for antifungal therapies is expected to continue its upward trajectory. Additionally, the expansion of antifungal drug options and the ...
Leqembi and Kisunla represent a great step forward in Alzheimer’s treatment. Still, patients need to jump through logistical hurdles to secure a prescription or insurance coverage. And they have to ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results